- In December, China Vanke reported contracted sales of 23.34 billion yuan.
- The year-to-date (YTD) contracted sales for China Vanke reached 246.02 billion yuan.
- Analysts’ ratings for China Vanke included 6 buy recommendations.
- There were 9 hold recommendations from analysts on China Vanke.
- Analysts also issued 4 sell recommendations for China Vanke.
A look at China Vanke (H) Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Vanke Co., Ltd., a property development company with a strong presence in major Chinese cities, has garnered promising Smartkarma Smart Scores across different factors. With a top score in both Value and Dividend, China Vanke (H) demonstrates solid financial health and a commitment to rewarding its investors. However, the company shows slightly lower scores in Growth, Resilience, and Momentum, indicating potential areas for improvement in its long-term performance.
Despite facing challenges in terms of growth, resilience, and momentum, China Vanke (H) remains an attractive investment option given its strong focus on value and dividends. Investors looking for stable returns and a company with a strong financial foundation may find China Vanke (H) to be a compelling opportunity in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
